These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 3038391

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats.
    Hartmann JF, Szemplinski M, Hayes NS, Keegan ME, Slater EE.
    J Hypertens; 1988 Aug; 6(8):677-83. PubMed ID: 2846685
    [Abstract] [Full Text] [Related]

  • 45. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O, Allegrini J, Clozel JP, Ménard J, Alhenc-Gelas F.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
    [Abstract] [Full Text] [Related]

  • 46. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition.
    Chappell MC, Gomez MN, Pirro NT, Ferrario CM.
    Hypertension; 2000 Jan; 35(1 Pt 2):348-52. PubMed ID: 10642323
    [Abstract] [Full Text] [Related]

  • 47. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
    Windt WA, van Dokkum RP, Kluppel CA, Jeronimus-Stratingh CM, Hut F, de Zeeuw D, Henning RH.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):231-40. PubMed ID: 18036585
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II.
    Sun Y, Ratajska A, Weber KT.
    J Lab Clin Med; 1995 Jul 02; 126(1):95-101. PubMed ID: 7602241
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
    Nelissen-Vrancken MH, Leenders PJ, Bost JG, Struijker-Boudier HA, Smits JF.
    Eur J Pharmacol; 1992 Jun 24; 217(1):49-55. PubMed ID: 1327817
    [Abstract] [Full Text] [Related]

  • 53. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
    Sica DA, Cutler RE, Parmer RJ, Ford NF.
    Clin Pharmacokinet; 1991 May 24; 20(5):420-7. PubMed ID: 1652404
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat.
    Okunishi H, Kawamoto T, Kurobe Y, Oka Y, Ishii K, Tanaka T, Miyazaki M.
    Clin Exp Pharmacol Physiol; 1991 Sep 24; 18(9):649-59. PubMed ID: 1659958
    [Abstract] [Full Text] [Related]

  • 56. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC.
    Kidney Int; 2005 Nov 24; 68(5):2189-96. PubMed ID: 16221218
    [Abstract] [Full Text] [Related]

  • 57. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP, Ennezat PV, Lisker J, Suryadevara V, Infeld J, Cukon S, Hammer A, Sonnenblick EH, Le Jemtel TH.
    Circulation; 2000 Feb 29; 101(8):844-6. PubMed ID: 10694521
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
    Hamming I, van Goor H, Turner AJ, Rushworth CA, Michaud AA, Corvol P, Navis G.
    Exp Physiol; 2008 May 29; 93(5):631-8. PubMed ID: 18192334
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.